ESRP1(1-606)-p-RAF1(227-648) fusion [cytosol]

Stable Identifier
R-HSA-6802523
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
20526349 Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

Shankar, S, Siddiqui, J, Kuefer, R, Chen, YB, Greenson, JK, Lafargue, CJ, Ramnarayanan, K, Han, B, Palanisamy, N, Demichelis, F, Esgueva, R, Dhanasekaran, SM, Giordano, TJ, Fullen, DR, Pflueger, D, Moeller, P, Rubin, MA, Maher, CA, Cao, Q, Cao, X, Ateeq, B, Banerjee, S, Bismar, TA, Tomlins, SA, Varambally, S, Kumar-Sinha, C, Chinnaiyan, AM, Johnson, TM, Suleman, K, Tan, P, Kalyana-Sundaram, S

Nat. Med. 2010
Participates
Other forms of this molecule
Modified Residues
Name
Insertion of residues 227 to 648 at 607 from UniProt:P04049 RAF1
Coordinate
607
Name
O-phospho-L-serine at 621
Coordinate
621
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O-phospho-L-serine at 338
Coordinate
338
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O4'-phospho-L-tyrosine at 341
Coordinate
341
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-tyrosine residue to O4'-phospho-L-tyrosine.
Name
O-phospho-L-threonine at 491
Coordinate
491
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-threonine residue to O-phospho-L-threonine.
Name
O-phospho-L-serine at 494
Coordinate
494
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
prostate cancer DOID:10283 NGP - New growth of prostate, neoplasm of prostate (disorder), tumor of the prostate, malignant tumor of prostate (disorder), prostate neoplasm, malignant tumor of the prostate, malignant tumor of prostate (disorder), prostatic cancer, prostatic neoplasm
Interactors (38)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P54253 ATX1      0.805 12
 UniProt:Q6ZRY4 RBPS2      0.742 5
 UniProt:P00488 F13A1  4 0.556 3
 UniProt:Q71SY5 MED25  1 0.556 3
 UniProt:P10809 HSPD1  6 0.556 3
 UniProt:Q13148 TADBP      0.556 6
 UniProt:P02766 TTR  2 0.556 3
 IntAct:EBI-25847655 CCSB      0.556 3
 UniProt:Q14203-5 DCTN1      0.556 3
 UniProt:Q92876 KLK6      0.556 3
 UniProt:P16284 PECAM1  5 0.556 3
 UniProt:O14901 KLF11      0.556 3
 UniProt:O14645 IDLC      0.556 3
 UniProt:P46379-2 BAG6      0.556 3
 UniProt:P48643 CCT5  1 0.556 3
 UniProt:P28329-3 P283293      0.556 3
 UniProt:P02489 CRYAA      0.556 3
 UniProt:Q86V38 Q86V38      0.556 3
 UniProt:Q8TDS5 OXER1  1 0.556 3
 UniProt:P86480 PR20D      0.556 3
 UniProt:Q13393 PLD1  4 0.556 3
 UniProt:P04792 HSBP1  3 0.556 3
 UniProt:Q03989 ARI5A      0.556 3
 UniProt:P34741 SDC2  20 0.556 3
 UniProt:Q9UMX0 UBQLN1  1 0.556 3
 UniProt:P08670 VIM  11 0.556 3
 UniProt:Q3LI72 KRTAP19-5  1 0.556 3
 UniProt:Q15038 DAZP2      0.556 3
 UniProt:O60333-2 KIF1B      0.556 3
 UniProt:Q96G42 KLD7B      0.556 3
 IntAct:EBI-25857482 CCSB      0.556 3
 UniProt:Q9Y649 Q9Y649      0.556 3
 UniProt:P13637 ATP1A3  1 0.556 3
 UniProt:Q9Y3C5 RNF11      0.556 3
 UniProt:P22607 FGFR3  20 0.556 3
 UniProt:O76024 WFS1  3 0.556 3
 UniProt:Q99666 RGPD5      0.527 2
 UniProt:O14715 RGPD8      0.527 2
Cite Us!